Dr. Dregalla holds a Ph.D. in Cell & Molecular Biology from Colorado State University, graduating in 2011. The graduate-level research was funded by NASA and focused on telomere and DNA-repair proteins with respect to DNA-repair and chromosomal stability following exposure to ionizing radiation. Following graduation, Dr. Dregalla assisted in the development of a functional research program to support a physician-owned autologous cell therapy clinic. Here, he found a passion for research in the field of orthobiologics and tissue-based therapies.
Beginning in 2014, Dr. Dregalla has focused on the development of human-derived acellular tissue-products to address unmet needs in the realm of wound care. He aspires to eventually bring similar technologies to orthopedics where quality, scientifically justified tissue-based technologies are severely lacking. Since 2019, Dr. Dregalla has worked with start-up companies, established medical device companies and physicians alike, offering laboratory-based services for QA/QC, laboratory-based projects for peer-reviewed publications, intellectual property, and FDA filings.
| Specialty |
Founder and Chief Scientific Officer |
